You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-079

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Severe Plaque-type Psoriasis Trial in Worldwide (Experimental : Secukinumab low dose, Experimental: Secukinumab high

Active, not recruiting
Has Results
  • Chronic Severe Plaque-type Psoriasis
  • Experimental : Secukinumab low dose
  • +3 more
  • San Antonio, Texas
  • +45 more
Jan 30, 2022

Plaque Psoriasis Trial in Worldwide (biological, radiation, drug)

Recruiting
  • Plaque Psoriasis
  • Secukinumab
  • +3 more
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +66 more
Jul 20, 2022

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

Endometrial Cancer, Recurrent Endometrial Cancer Trial in United States (LY3023414)

Completed
  • Endometrial Cancer
  • Recurrent Endometrial Cancer
  • Basking Ridge, New Jersey
  • +5 more
Sep 13, 2022

Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

Recruiting
  • Autoimmunity, Inflammation
  • Secukinumab s.c. injection
  • Fullerton, California
  • +93 more
Jul 14, 2022

Migraine Trial in Worldwide (Atogepant, Placebo for Atogepant, Topiramate)

Not yet recruiting
  • Migraine
  • Innsbruck, Tirol, Austria
  • +84 more
Feb 20, 2023

Eosinophilic Esophagitis Trial in Worldwide (CC-93538)

Recruiting
  • Eosinophilic Esophagitis
  • Birmingham, Alabama
  • +300 more
Aug 17, 2022

COPD (COPD), Chronic Bronchitis Trial in Worldwide (MEDI3506, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • MEDI3506
  • Placebo
  • Sheffield, Alabama
  • +125 more
Jul 28, 2022

Eosinophilic Esophagitis Trial in Worldwide (CC-93538, Placebo)

Recruiting
  • Eosinophilic Esophagitis
  • Birmingham, Alabama
  • +417 more
Jan 23, 2023

ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)

Completed
Has Results
  • ASCVD
  • +2 more
  • Inclisiran Sodium
  • Placebo
  • Chomutov, Czechia
  • +69 more
Aug 3, 2020

Systemic Lupus Erythematosus, Lupus Erythematosus, Systemic Trial in United States (TAK-079, TAK-079 Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Lupus Erythematosus, Systemic
  • Anniston, Alabama
  • +18 more
Nov 8, 2021

HCV Infection Trial in Worldwide (EBR/GZR FDC Tablet, Placebo, Grazoprevir Oral Granules)

Completed
Has Results
  • HCV Infection
  • EBR/GZR FDC Tablet
  • +3 more
  • San Francisco, California
  • +14 more
Jun 8, 2021

Nursing, Education Trial in Seoul (AR guidance with Hololens 2)

Enrolling by invitation
  • Nursing
  • Education
  • AR guidance with Hololens 2
  • Seoul, Korea, Republic of
    Samsung Medical Centre
Nov 17, 2022

Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • Phoenix, Arizona
  • +156 more
Jul 4, 2022

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Influenza Trial in Worldwide (Baloxavir Marboxil)

Recruiting
  • Influenza
  • Baloxavir Marboxil
  • Birmingham, Alabama
  • +46 more
Jan 11, 2023

Multiple Chronic Conditions Trial in Brussels (Focus group meetings, Individual interviews)

Recruiting
  • Multiple Chronic Conditions
  • Focus group meetings
  • Individual interviews
  • Brussels, Belgium
    Mareike Kaemmerer
Mar 9, 2023

Advanced Solid Tumor Trial in Chiba, Tokyo (DS-1471a)

Recruiting
  • Advanced Solid Tumor
  • Chiba, Japan
  • +1 more
Oct 5, 2023

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee Trial in United States (Cebranopadol (GRT6005) Low-Dose Range,

Completed
  • Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
  • Cebranopadol (GRT6005) Low-Dose Range
  • +3 more
  • Birmingham, Alabama
  • +82 more
Jul 13, 2021

Diabetes, Type 1 Trial in Cleveland (Virtual Educational Program)

Completed
  • Diabetes Mellitus, Type 1
  • Virtual Educational Program
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Oct 26, 2022

Breast Cancer Trial in London (Tamoxifen Citrate 20Mg Tab, Placebo)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen Citrate 20Mg Tab
  • Placebo
  • London, England, United Kingdom
    Queen Mary University of London
Jan 13, 2023

Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Sanprobi IBS®
  • Kościerzyna, Poland
    Unit of Surgery with Unit of Oncological Surgery in Koscierzyna
Aug 24, 2023

Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia Trial in Brooklyn (Sham Light, Bright Light Therapy)

Not yet recruiting
  • Prader-Willi Syndrome
  • +5 more
  • Sham Light
  • Bright Light Therapy
  • Brooklyn, New York
    Maimonides Medical Center
Jul 2, 2023

Hyperlipidaemia Trial in Worldwide (AZD8233, Placebo)

Active, not recruiting
  • Hyperlipidaemia
  • Huntsville, Alabama
  • +65 more
Jun 24, 2022

Idiopathic Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
  • +442 more
Aug 15, 2023